Medical treatment for primary sclerosing cholangitis: Risk versus benefit

Paul Angulo, Keith Lindor

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)871-872
Number of pages2
JournalHepatology
Volume32
Issue number4 I
StatePublished - 2000
Externally publishedYes

Fingerprint

Ursodeoxycholic Acid
Sclerosing Cholangitis
Azathioprine
Prednisolone
Combination Drug Therapy

ASJC Scopus subject areas

  • Hepatology

Cite this

Medical treatment for primary sclerosing cholangitis : Risk versus benefit. / Angulo, Paul; Lindor, Keith.

In: Hepatology, Vol. 32, No. 4 I, 2000, p. 871-872.

Research output: Contribution to journalArticle

@article{df2d68fc562b403abdf4119dc6c1b5ee,
title = "Medical treatment for primary sclerosing cholangitis: Risk versus benefit",
author = "Paul Angulo and Keith Lindor",
year = "2000",
language = "English (US)",
volume = "32",
pages = "871--872",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "4 I",

}

TY - JOUR

T1 - Medical treatment for primary sclerosing cholangitis

T2 - Risk versus benefit

AU - Angulo, Paul

AU - Lindor, Keith

PY - 2000

Y1 - 2000

UR - http://www.scopus.com/inward/record.url?scp=0033802365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033802365&partnerID=8YFLogxK

M3 - Article

C2 - 11003638

AN - SCOPUS:0033802365

VL - 32

SP - 871

EP - 872

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 4 I

ER -